Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
To overcome this limitation, a clinical study combines decitabine and tetrahydrouridine (THU), a cytosine deaminase inhibitor, as a therapeutic strategy for inducing HbF (ClinicalTrials.gov Identifier: NCT01685515)
doi: 10.3389/fimmu.2023.1213159 55 LuY.ZhangZ.LiangX.ChenY.ZhangJ.YiH.et al
A significant decrease in the levels of IL-10 was also observed in the plasma samples ( Figure 5G ) at 3-months post-L-GSH supplementation
Meldrum DR, Casper RF, Diez-Juan A, Simon C, Domar AD, Frydman R
US$ 25.84
US$ 22.35
US$ 28.73
US$ 26.72
US$ 22.80
US$ 24.98
